Literature DB >> 15668322

B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination.

Takechiyo Yamada1, Ke Zhang, Akiko Yamada, Daocheng Zhu, Andrew Saxon.   

Abstract

B lymphocyte stimulator (BLyS), a member of the tumor necrosis factor ligand superfamily, has potent costimulatory activity on B cells. To investigate BLyS signaling in Ig class switching, we examined whether BLyS could control stress-activated protein kinases in human B cells as well as whether BLyS could induce human Ig class switch recombination (CSR) and expression of activation-induced cytidine deaminase (AID). BLyS induced the phosphorylation p38 mitogen-activated protein kinase (p38 MAPK) and c-Jun N-terminal kinase (JNK) in human B cells. As evidence of Ig class switch, BLyS plus interleukin (IL)-4 induced generation of switch circle transcripts (CTs) to gamma 1-2, gamma 4, and epsilon, whereas BLyS plus IL-10 induced gamma 1-2 CTs only. BLyS strongly induced AID expression in the presence of IL-4. Treatment with SB203580, a specific inhibitor of p38 MAPK signaling, almost completely reversed BLyS-induced CSR and AID expression in human B cells. The switch vector assay also showed that BLyS induced CSR in the presence of IL-4 in Ramos 2G6 human B cells and that SB203580 reversed CSR. These results indicate that BLyS-activated p38 MAPK plays an essential role in BLyS-induced AID-expression and CSR in human B cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668322     DOI: 10.1165/rcmb.2004-0317OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  15 in total

1.  A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Authors:  Hyunjoo Lee; Shabirul Haque; Jennifer Nieto; Joshua Trott; John K Inman; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

2.  Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.

Authors:  Daniela Frasca; Richard L Riley; Bonnie B Blomberg
Journal:  Exp Gerontol       Date:  2006-10-25       Impact factor: 4.032

3.  Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF.

Authors:  Chaim O Jacob; Luminita Pricop; Chaim Putterman; Michael N Koss; Yi Liu; Maria Kollaros; Sarah A Bixler; Christine M Ambrose; Martin L Scott; William Stohl
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

Review 4.  The Immunologic Paradoxes of IgG4-Related Disease.

Authors:  Xiao Xiao; Min Lian; Weici Zhang; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

5.  Efficient Culture of Human Naive and Memory B Cells for Use as APCs.

Authors:  Kuei-Ying Su; Akiko Watanabe; Chen-Hao Yeh; Garnett Kelsoe; Masayuki Kuraoka
Journal:  J Immunol       Date:  2016-10-10       Impact factor: 5.422

6.  TGF-β1 stimulates mouse macrophages to express APRIL through Smad and p38MAPK/CREB pathways.

Authors:  Young-Saeng Jang; Jae-Hee Kim; Goo-Young Seo; Pyeung-Hyeun Kim
Journal:  Mol Cells       Date:  2011-06-23       Impact factor: 5.034

7.  Oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza A virus.

Authors:  Etsuhisa Takahashi; Kosuke Kataoka; Irene L Indalao; Keiko Konoha; Kazuyuki Fujii; Junji Chida; Dai Mizuno; Kohtaro Fujihashi; Hiroshi Kido
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

8.  Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity.

Authors:  William Stohl; Noam Jacob; William J Quinn; Michael P Cancro; Huaxin Gao; Chaim Putterman; Xiaoni Gao; Luminita Pricop; Michael N Koss
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 9.  [IgG4-related disease].

Authors:  J Loock; B Manger
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

10.  TGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells.

Authors:  Dániel Szili; Zsuzsanna Bankó; Eszter Angéla Tóth; György Nagy; Bernadette Rojkovich; Tamás Gáti; Melinda Simon; Zoltán Hérincs; Gabriella Sármay
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.